Randomized, Open Label, Active Controlled Comparative Study to Assess Safety, Efficacy of Mometasone & Formoterol Versus Fluticasone & Formoterol Dry Powder Inhaler in Treatment of Mild to Moderate Persistent Asthma

Background: This study conducted to assess and compare the safety and efficacy of Mometasone & Formoterol versus Fluticasone & Formoterol. in patients with mild to moderate persistent asthma on symptom control and rescue medication usage. Method: The present study was conducted during Ma...

Full description

Bibliographic Details
Published in:	National Journal of Community Medicine
Main Authors:	Parasuramalu B G, Sathish Chandra MR, Huliraj N, Giriyanna Gowda, Gangaboraiah
Format:	Article
Language:	English
Published:	Medsci Publications 2015-06-01
Subjects:	Mild to moderate persistent Asthma dry powder inhaler safety efficacy
Online Access:	https://njcmindia.com/index.php/file/article/view/1177

Similar Items

COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
by: V. A. Nikitin, et al.
Published: (2016-03-01)

An Indian perspective on the use of fluticasone/formoterol in asthma and chronic obstructive pulmonary disease patients
by: Rahul Sharma, et al.
Published: (2021-01-01)

Effect of fluticasone propionate/formoterol and fluticasone furoate/vilanterol on adolescents with chronic bronchial obstruction
by: Tiina Helena Tanninen, MD, et al.
Published: (2024-08-01)

Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study
by: David B. Price, et al.
Published: (2018-06-01)

The Extra Cost Due to Non-Adherence to Inhaled Treatments in Adolescents with Mild-to-Moderate Persistent Asthma
by: Roberto Walter Dal Negro, et al.
Published: (2023-03-01)

Efficacy and safety of mometasone furoate/formoterol combination in patients with bronchial asthma
by: A. V. Emelyanov
Published: (2015-12-01)

Inhalation of Budesonide/Formoterol Increases Diaphragm Muscle Contractility
by: Chiyohiko Shindoh, et al.
Published: (2012-01-01)

Utility and effectiveness of Symbicort® Turbuhaler® (oral inhalation containing budesonide and formoterol) in a patient with severe asthma after permanent tracheostomy
by: Kohhei Maeda, et al.
Published: (2018-09-01)

Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients
by: Hyun-moon Back, et al.
Published: (2020-04-01)

A Comparison of Long-Term Anti-Inflammatory Effect of Two ICS/LABA Combination Inhalers; Fix-Dosed Maintenance Therapy with Budesonide/Formoterol and Salmeterol/Fluticasone
by: Masayuki Hojo, et al.
Published: (2014-01-01)

Inhaled Formoterol-Fluticasone Single Inhaler Therapy in Asthma: Real-World Efficacy, Budget Impact, and Potential to Improve Adherence
by: V. Rajesh, et al.
Published: (2020-01-01)

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
by: Mohsen Sadatsafavi, et al.
Published: (2021-10-01)

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
by: Roberto W. Dal Negro, et al.
Published: (2018-06-01)

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD
by: Paolo Montuschi, et al.
Published: (2018-04-01)

Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma
by: Prosser TR, et al.
Published: (2015-06-01)

Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation
by: Sergey K. Zyryanov, et al.
Published: (2022-08-01)

Efficacy of Budesonide in Combination with Formoterol in Patients with Inadequately Controlled Asthma on Fluticasone in Combination with Salmeterol
by: Yoshihiro Kanemitsu, et al.
Published: (2012-01-01)

Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform®) for the treatment of asthma
by: Tan RA, et al.
Published: (2014-09-01)

Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report
by: Antonio Maiorano, et al.
Published: (2024-03-01)

Real-world use of inhaled corticosteroid/formoterol as needed in adults with mild asthma: the PRIME study
by: Guy Brusselle, et al.
Published: (2024-09-01)

Efficacy and safety of combined medium-dose mometasone furoate/formoterol (MF/F) in persistent asthmatics
by: Nathan Robert A, et al.
Published: (2010-11-01)

Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting
by: Perrone V, et al.
Published: (2016-11-01)

Non-interventional study of the safety and effectiveness of fluticasone propionate/formoterol fumarate in real-world asthma management
by: Vibeke Backer, et al.
Published: (2018-09-01)

Beclometasone Dipropionate/Formoterol Fumarate is Similarly Effective to Budesonide/Formoterol Fumarate in Chinese Patients with COPD: The FORSYYN Double-Blind, Randomised Study
by: Fuqiang Wen, et al.
Published: (2024-12-01)

Asthma Control Can Be Maintained after Fixed-Dose, Budesonide/Formoterol Combination Inhaler Therapy is Stepped Down from Medium to Low Dose
by: Masayuki Hojo, et al.
Published: (2013-01-01)

An individualized, adjustable maintenance regimen of budesonide/formoterol provides effective asthma symptom control at a lower overall dose than fixed dosing
by: L Meyer, et al.
Published: (2003-05-01)

A cost-effectiveness analysis comparing single-inhaler extrafine beclomethasone/formoterol/glycopyrronium bromide against other SITTs in adult patients with uncontrolled asthma in England
by: Ioanna Vlachaki, et al.
Published: (2025-05-01)

Protocol for the INFORM ASTHMA Trial: budesonide–formoterol reliever in adults with asthma on maintenance inhaled corticosteroid
by: Jonathan Noble, et al.
Published: (2025-07-01)

Fixed-dose combination fluticasone/formoterol for asthma treatment in a real-world setting: meta-analysis of exacerbation rates and asthma control
by: Alberto Papi, et al.
Published: (2023-01-01)

Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain
by: Trigueros JA, et al.
Published: (2022-11-01)

Role of inhaled corticosteroids/formoterol in relieving acute asthma as compared to traditional salbutamol in children 6 to 11 years old on maintenance and reliever therapy step 3 and above as per the Global Initiative for Asthma guideline
by: Danish Abdul Aziz, et al.
Published: (2025-06-01)

Problem of mild bronchial asthma revisited
by: Y. G. Belotserkovskaya, et al.
Published: (2019-08-01)

Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD
by: Martyn R. Partridge, et al.
Published: (2009-08-01)

Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy
by: Albertson TE, et al.
Published: (2016-12-01)

Validated chromatographic methods for the simultaneous determination of Mometasone furoate and Formoterol fumarate dihydrate in a combined dosage form
by: Hanan A. Merey, et al.
Published: (2016-06-01)

Clinical experience of using formoterol/budesonide in patients with chronic obstructive pulmonary disease
by: I. V. Demko, et al.
Published: (2021-10-01)

Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD
by: Kerwin EM, et al.
Published: (2018-05-01)

Chromium and formoterol therapy for obesity-induced asthma in rats
by: Rania T. Ibrahim, et al.
Published: (2025-04-01)

Comparison of Budesonide/formoterol versus Fluticasone furoate/vilanterol as maintenance and reliever therapy for asthma control: a real-world observational study
by: Wei-Chun Huang, et al.
Published: (2024-08-01)

Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma
by: Antonio Maiorano, et al.
Published: (2025-10-01)